Literature DB >> 6487765

Effect of hyperthermia on tumor blood flow.

W Müller-Klieser, P Vaupel.   

Abstract

Differences in blood perfusion rates between tumors and normal tissue can be utilized to selectively heat many solid tumors. Blood flow in normal tissues is considerably increased at temperatures commonly applied during localized hyperthermia. In contrast, tumor blood flow may respond to localized heat typically in two different blood flow patterns: Flow may either decrease continuously with increasing exposure time and/or temperature or flow may exhibit a transient increase followed by a decline. A decrease in blood flow at high thermal doses can be observed in most of the tumors, whereas an increase in flow at low thermal doses seems to occur less frequently. The inhibition of blood flow at high thermal doses may lead to physiological changes in the microenvironment of the cancer cells that increase the cell killing effect of hyperthermia. Flow increases at low thermal doses can enhance the efficiency of other treatment modalities, such as irradiation or the administration of antiproliferate drugs.

Entities:  

Mesh:

Year:  1984        PMID: 6487765     DOI: 10.3233/bir-1984-21412

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  3 in total

1.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  Control time reduction using virtual source projection for treating a leg sarcoma with nonlinear perfusion.

Authors:  Kung-Shan Cheng; Yu Yuan; Zhen Li; Paul R Stauffer; William T Joines; Mark W Dewhirst; Shiva K Das
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-12

3.  Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice.

Authors:  G Wiedemann; S Roszinski; A Biersack; C Weiss; T Wagner
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.